Bank of Montreal’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-9,761
| Closed | -$176K | – | 5039 |
|
|
2020
Q2 | $176K | Buy |
9,761
+8,913
| +1,051% | +$124K | ﹤0.01% | 2797 |
|
|
2020
Q1 | $6K | Sell |
848
-11,794
| -93% | -$147K | ﹤0.01% | 3659 |
|
|
2019
Q4 | $301K | Buy |
12,642
+3,051
| +32% | +$84.2K | ﹤0.01% | 2941 |
|
|
2019
Q3 | $257K | Buy |
9,591
+983
| +11% | +$27.6K | ﹤0.01% | 2759 |
|
|
2019
Q2 | $233K | Buy |
8,608
+5,285
| +159% | +$166K | ﹤0.01% | 2841 |
|
|
2019
Q1 | $115K | Buy |
3,323
+1,118
| +51% | +$32.3K | ﹤0.01% | 3000 |
|
|
2018
Q4 | $43K | Buy |
2,205
+24
| +1% | +$494 | ﹤0.01% | 3345 |
|
|
2018
Q3 | $58K | Buy |
2,181
+537
| +33% | +$17.5K | ﹤0.01% | 3331 |
|
|
2018
Q2 | $61K | Buy |
1,644
+986
| +150% | +$37.7K | ﹤0.01% | 3344 |
|
|
2018
Q1 | $21K | Sell |
658
-26
| -4% | -$1.14K | ﹤0.01% | 3548 |
|
|
2017
Q4 | $33K | Buy |
684
+149
| +28% | +$7.54K | ﹤0.01% | 3427 |
|
|
2017
Q3 | $29K | Hold |
535
| – | – | ﹤0.01% | 3411 |
|
|
2017
Q2 | $30K | Hold |
535
| – | – | ﹤0.01% | 3396 |
|
|
2017
Q1 | $21K | Hold |
535
| – | – | ﹤0.01% | 3361 |
|
|
2016
Q4 | $10K | Hold |
535
| – | – | ﹤0.01% | 3614 |
|
|
2016
Q3 | $12K | Hold |
535
| – | – | ﹤0.01% | 3523 |
|
|
2016
Q2 | $13K | Sell |
535
-4,703
| -90% | -$116K | ﹤0.01% | 3533 |
|
|
2016
Q1 | $107K | Buy |
5,238
+4,228
| +419% | +$134K | ﹤0.01% | 2774 |
|
|
2015
Q4 | $52K | Buy |
1,010
+533
| +112% | +$25.8K | ﹤0.01% | 3029 |
|
|
2015
Q3 | $20K | Buy |
+477
| New | +$23K | ﹤0.01% | 3259 |
|
|
2014
Q3 | – | Sell |
-270
| Closed | -$8K | – | 4586 |
|
|
2014
Q2 | $8K | Buy |
+270
| New | +$6.54K | ﹤0.01% | 3984 |
|
|
2013
Q4 | – | Sell |
-22
| Closed | -$1K | – | 3999 |
|
|
2013
Q3 | $1K | Buy |
+22
| New | +$524 | ﹤0.01% | 3745 |
|
Bank of Montreal's PTLA Position: Q3 2020 in Review
Bank of Montreal sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 9,761 shares — an estimated $176K sold.
Bank of Montreal first reported a position in PTLA in Q3 2013 and held it in 22 quarters. The position peaked at $301K in Q4 2019. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Bank of Montreal reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Bank of Montreal sold 9,761 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $176K.
- Bank of Montreal first reported a position in Portola Pharmaceuticals, Inc. in Q3 2013 and held it in 22 quarters.
- Bank of Montreal's Portola Pharmaceuticals, Inc. position peaked at $301K in Q4 2019.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Bank of Montreal's 13F filing for Q3 2020, filed 12 Nov 2020.